The American College of Medical Genetics and Genomics (ACMG) has appointed Robert D. Steiner as editor in chief of its peer-reviewed journal, Genetics in Medicine. Steiner will succeed James P. Evans, who will retire at the end of 2018. Steiner has been the Deputy Editor of GIM since 2011 and a section editor since 2006. He is Professor (Clinical) of Pediatrics at the University of Wisconsin School of Medicine and Public Health, Chief Medical Officer for PreventionGenetics and geneticist and Medical Director at Marshfield Clinic Health System. He served as Resident in Pediatrics at The University of Cincinnati/Cincinnati Children's Hospital and Medical Center and then trained in medical genetics at The University of Washington/Seattle Children's Hospital and Regional Medical Center.
Steiner most recently served as Chief Medical Officer at Acer Therapeutics. Prior to joining Acer, Steiner was Executive Director, Marshfield Clinic Research Institute, Chief Science Officer Marshfield Clinic, and Executive Associate Director, Institute for Clinical and Translational Research (ICTR, NIH CTSA grant), University of Wisconsin. For most of his career, he was a faculty member at Oregon Health & Science University (OHSU), ultimately serving as Credit Unions for Kids Professor of Pediatric Research, Professor of Pediatrics and Molecular & Medical Genetics, and (tenured) Vice Chair for Research in Pediatrics at Doernbecher Children's Hospital, in Portland, Oregon, USA.
Steiner is an active clinician in the field of medical genetics, with specific interests in inherited metabolic diseases, metabolic bone diseases, genetic/biochemical/genomic testing, and newborn screening. In addition, he is an accomplished researcher, having served as the Principal Investigator for more than a dozen clinical trials and clinical research studies on Smith-Lemli-Opitz Syndrome (SLOS), Osteogenesis Imperfecta, Phenylketonuria, Lysosomal Storage Diseases, and others. Steiner has authored or co-authored over 150 peer-reviewed original research articles in many high impact journals as well as more than 80 reviews, book chapters, and letters on genetic diseases, genetic testing, and related topics.
Steiner is a member of several professional societies, including the American Society of Human Genetics, American College of Medical Genetics and Genomics, Society for Inherited Metabolic Disorders, and the Society for the Study of Inborn Errors of Metabolism. Steiner has had numerous appointments on national committees and advisory boards including as a member and Treasurer of the Board of Directors of the American College of Medical Genetics and Genomics and of the Health Care System Research Network Board of Governors, the Institute of Medicine advisory panel on accelerating rare disease research, serving as Chair of the American College of Medical Genetics and Genomics working group on Pompe disease, as a Standing and Steering Committee member of the Newborn Screening Translational Research Network, as an NIH Study Section member, and as a member of the American College of Medical Genetics and Genomics Therapeutics Committee. He was a member of the expert panel convened in 2005 by the Health Research Services Agency (HRSA) that reviewed the status of newborn screening in the US and recommended expansion of the program to the US Secretary of Health and Human Services.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
